相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Disorders?
Moussa B. H. Youdim
RAMBAM MAIMONIDES MEDICAL JOURNAL (2015)
D-512 and D-440 as Novel Multifunctional Dopamine Agonists: Characterization of Neuroprotection Properties and Evaluation of In Vivo Efficacy in a Parkinson's Disease Animal Model
Soumava Santra et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson's Disease
Christopher A. Lieu et al.
PLOS ONE (2013)
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
Moussa B.H. Youdim
Experimental Neurobiology (2013)
Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl) piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization
Mark Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson's Disease
Sanjib Gogoi et al.
CHEMMEDCHEM (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
6-Hydroxydopamine-Induced PC12 Cell Death is Mediated by MEF2D Down-regulation
Min-Kyoung Kim et al.
NEUROCHEMICAL RESEARCH (2011)
Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Disorders?
B. Moussa et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2010)
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2009)
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE
Donna W. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Redox imbalance in Parkinson's disease
Shankar J. Chinta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
A rapid method combining Golgi and Nissl staining to study neuronal morphology and cytoarchitecture
Nadia Pilati et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties
Cornelis J. Van der Schyf et al.
CURRENT ALZHEIMER RESEARCH (2007)
Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death
AP Signore et al.
JOURNAL OF NEUROCHEMISTRY (2006)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
MPTP as a mitochondrial neurotoxic model of Parkinson's disease
S Przedborski et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Neuroprotective effects of the novel D-3/D-2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
JN Joyce et al.
EXPERIMENTAL NEUROLOGY (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen - Role of reactive oxygen and nitrogen species
S Kotamraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Extracellular toxicity of 6-hydroxydopamine on PC12 cells
D Blum et al.
NEUROSCIENCE LETTERS (2000)
Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants:: Potential implication in relation to the pathogenesis of Parkinson's disease
R Soto-Otero et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease
W Linert et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
分享论文
